Zevra Therapeutics Statistics

NASDAQ: ZVRAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

11.36+0.36 (+3.27%)

Market open · Delayed 15 min · as of Oct 9, 12:13 PM ET

Zevra Therapeutics by the numbers

Zevra Therapeutics has a market capitalization of $674.6 million based on 59.38M shares outstanding. Its trailing P/E ratio is 12.3, above the 3-company peer median of 5.3, and its forward P/E is 10.6. The stock trades 0.6% below its 50-day average and 7.1% above its 200-day average.

Average daily trading volume is 1.11M shares, or about $12.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ZVRA valuation vs. peer median

ZVRA compared with the median of 8 peer companies
Metric	ZVRA	Peer median	Difference
Market cap	$674.60M	$644.54M	+5%
P/E (TTM)	12.3	5.3	+133%
Avg. volume	1.11M	1.19M	-7%

Peer median across 8 companies: FTH, NVCT, IRWD, ABUS, PHAR, SLN, CLYM, SGMT.

Valuation

Market cap: $674.60M
P/E (TTM): 12.35
Forward P/E: 10.55
EPS (TTM): $0.92
Shares outstanding: 59.38M

Price and trading

Previous close: 11.00
Open: 10.95
Day range: 10.95 – 11.36
52-week range: 8.01 – 15.04
52-week change: +3.38%
50-day moving average: 11.42
200-day moving average: 10.61
Beta: —
Volume: 203.07K
Average volume: 1.11M

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 4, 2026

Additional statistics

Market Cap: 674.60M
Pe: 12.35
Forward Pe: 10.55
Eps: 0.92
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 15.04
Week52 Low: 8.01
Avg Volume: 1.11M
Shares Outstanding: 59.38M
Ma50: 11.42
Ma200: 10.61
Earnings Date: Nov 4, 2026
Pct From52w High: -24.44%
Pct From52w Low: 41.82%